Diagnosis
By Ciara Donlon, founder & CEO of MOSS A baby is born. In the first hours of their life, before they have tasted food, before they have felt sunlight, before they have learned the sound of their own name, they are wrapped in a nappy. That nappy, in most cases, is made from plastic, synthetic [...]
Cambridge health tech company TidalSense has secured £14.2m in funding led by Cross-Border Impact Ventures to expand its AI-powered lung disease test across the NHS and into Europe and the US. The investment, which also includes returning backers BGF, Airstream Capital and Foresight Group, will fund the rollout of a handheld diagnostic device that can [...]
Contrast-enhanced mammography (CEM) has shown promise for women at higher risk of breast cancer, with follow-up screening showing greater specificity and accuracy. Cancer detection rates remained consistent during repeat screening, while specificity improved compared with baseline examinations. Specificity shows how accurately a test identifies people who do not have the disease, helping to reduce unnecessary [...]
Davunetide may significantly slow the progression of a fatal brain disease in women, according to a new analysis of clinical trial data. The findings indicate that women and men with progressive supranuclear palsy (PSP) may respond differently to the experimental treatment. Progressive supranuclear palsy, or PSP, is a rare and fatal neurodegenerative disease. [...]
A preeclampsia study has found unusual cell activity in mothers and babies that could reveal new targets for treatment. The condition affects 2 to 4 per cent of pregnancies worldwide and is a leading cause of maternal and foetal mortality. There is currently no cure, and severe cases can put both the mother and baby [...]
A new reporting tool built specifically for obstetrics and maternal-fetal medicine has launched, aimed at teams managing increasingly complex pregnancies with limited time and resources. Trice Imaging has released Trice Workspace Reporting, which connects imaging, reporting and longitudinal patient data in a single workflow to support faster clinical decision making. Birth rates are falling worldwide, [...]
Two endometriosis tests could cut years from diagnosis after NICE backed their temporary NHS use in England and Wales. EndoSure and Endotest have been recommended in draft guidance, with one able to provide results in 45 minutes. Endometriosis affects around one in 10 women of reproductive age. It occurs when tissue similar to the womb [...]
Xella Health has launched what it calls the first AI precision health platform built for the XX chromosome. The company says it aims to address a lack of diagnostic precision and clinical research focused on female biology. Women make up half of the population and account for 80 per cent of consumer healthcare decisions, but [...]
Women with endometriosis or painful periods were four to five times more likely to receive an STI diagnosis, a large Japanese study found. Endometriosis occurs when tissue similar to the lining of the womb grows outside the womb. Although not strictly a menstrual disorder, it can cause pain, irregular periods and infertility. The [...]
WID-easy, the only non-invasive triage test for endometrial cancer in routine use in a European public health system, has been cited in Germany's highest-tier clinical guidance; a marker that non-invasive detection is reaching clinical maturity. The vaginal-swab test designed to spare women unnecessary invasive procedures has been referenced in the updated German S3 Guideline on [...]
Newsletter
Sign up for free weekly updates
The latest femtech news, research and investment, straight to your inbox.
















